May 2024: The Ozempic Craze: In the Perspective of Antibody Drugs

Ozempic, a brand name for the drug semaglutide, was originally developed to manage type 2 diabetes by improving blood sugar control. As a GLP-1 receptor agonist, it mimics a hormone that regulates glucose metabolism and appetite. Beyond its success in diabetes treatment, Ozempic has garnered signifi

May 30, 2024
The Role and Development of TCR-like Antibodies in Cancer Immunotherapy

Explore the role of TCR-like antibodies in targeting peptide-MHC complexes for precise cancer treatment, including development techniques and therapeutic applications.

May 29, 2024
Week 4, May 2024: Extensive-Stage Small-Cell Lung Cancer

ADCs for ES-SCLC. Image credit: DOI: 10.3390/genes15060701Extensive-stage small-cell lung cancer (ES-SCLC) is a particularly aggressive form of lung cancer characterized by rapid growth and early metastasis. Antibody drugs, especially immune checkpoint inhibitors, have emerged as a promising treatme

May 28, 2024
Antibody Basics: Part 8 - Therapeutic targets - Oncology: What is cancer immunotherapy?

Discover cancer immunotherapy techniques like monoclonal antibodies, checkpoint inhibitors, & ADCs. Learn how targeted delivery & tumor selectivity improve cancer treatment.

May 24, 2024
The Role of Antibody Production in Vaccination: From Development to Immune Response

Explore how vaccines stimulate antibody production, the mechanisms behind immune responses, and factors influencing vaccine efficacy for long-term immunity.

May 22, 2024
Week 3, May 2024: A Continued Look at the Progress of COVID Therapies

Image credit: DOI: 10.1038/s41577-021-00542-xThe progress of COVID-19 therapies has seen remarkable strides, particularly in the development and application of antibody-based treatments. Early in the pandemic, the focus was on supportive care, but the rapid advancement in antibody therapies has sign

May 21, 2024
Navigating the Landscape of CAR-T Cell Engineering with Antibody Discovery

Examine how antibody discovery drives CAR-T cell engineering, enhancing specificity, reducing toxicity, and advancing next-generation cancer immunotherapies.

May 20, 2024
Muronomab: The First Approved Monoclonal Antibody

Discover the history of Muronomab (Orthoclone OKT3), the first monoclonal antibody approved by the FDA for preventing transplant rejection & its impact on immunology.

May 16, 2024
Biointron Hosted a Lunch & Learn Session: “Accelerating Antibody Development and ADCs”

Highlights from Biointron’s Lunch & Learn with MassBio: HTP antibody platforms, alpaca VHH discovery, bispecific antibodies, & ADC development advancements.

May 10, 2024
Week 1, May 2024: B Cells Producing Antibodies

DOI:10.1126/science.adg0564 B cells, or B lymphocytes, are a crucial component of the adaptive immune system andhumoral immunity. They originate from the bone marrow and mature in secondary lymphoid organs, such as the spleen and lymph nodes. The B ce

May 09, 2024
Engineered Antibody Formats: A Historical Perspective

Discover the evolution of engineered antibody formats from monoclonal to bispecific antibodies, highlighting milestones in immunotherapy and clinical applications.

May 08, 2024
Antibody Basics: Part 7 - Functions in the human body: Understanding the key roles of antibodies

Learn how antibodies neutralize pathogens, aid in vaccine development, & enhance immune responses through opsonization. Explore their vital role in human health.

Apr 27, 2024
Critical Reagents in Therapeutic Antibody Development: Why They Matter

Explore the role of anti-idiotype antibodies & critical reagents in therapeutic antibody development, ensuring specificity, potency & safety in drug testing

Apr 24, 2024
Antibody Basics: Part 6 - Antibody formats: Antibody-Drug Conjugates (ADCs)

Explore ADCs in antibody research, combining monoclonal antibodies with cytotoxic drugs for precise cancer targeting. Learn their history, design, and benefits.

Apr 19, 2024
Week 2, Apr 2024: Cancer Research Trends at AACR

Here at the AACR Annual Meeting 2024, there are over 7000 abstracts, 300 poster presentations, and 50 symposia all about cancer research. A few topics that are currently trending in the conference include cancer vaccines, AI for diagnostics, novel immunotherapies, and antibody-drug conjugates (ADCs) as a new modality.

Apr 11, 2024

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.